NAMUR, Belgium—Sunrise, a sleep disorder diagnostics technology company, announced it has appointed a new chief growth officer, acquired California-based sleep clinic Dreem Health and has made plans to bring sleep care to the United States through telehealth services and online-based solutions.
“As we build out our U.S. presence, Sunrise is set to innovate the global sleep health market,” said Laurent Martinot, founder and CEO of Sunrise. “Since launching Sunrise in 2015, we've seen impressive growth driven by innovations in home sleep testing. However, the pace of change hasn't been fast enough, and there's still a major need for sleep health education. At Sunrise, we are committed to ensuring sleep disorders are properly recognized, diagnosed and treated. With strategic moves like the acquisition of Dreem Health and the appointment of Laura Warnier as chief growth officer, we’re strengthening our capabilities and establishing Sunrise as the global leader in sleep health.”
Laura Warnier, the company’s new chief growth officer, has a background in scaling startups, sales and marketing. At Sunrise, Warnier plans to oversee growth by building and managing the sales and marketing teams. Within the new role, Warnier intends to scale Sunrise and increase revenue.
“I’m joining Sunrise at such a pivotal moment, and I’m looking forward to advancing Sunrise’s mission of effectively diagnosing and treating sleep disorders on a global scale,” Warnier said. “The sleep care industry has been historically overlooked, leaving a massive area for growth. With close to one billion people globally struggling with sleep apnea—80% of which are undiagnosed—our team is committed to becoming the category leader in sleep disorder diagnosis and treatment.”
The partnership between Sunrise and Dreem Health aims to improve access to Sunrise’s sleep diagnostic and care devices. By pairing Sunrise’s diagnostic technology with Dreem Health’s insurer partnerships and Medicare, the company aims to accelerate patient access to sleep care. Additionally, the company seeks to provide U.S. residents with more access to Dreem Health’s licensed providers that evaluate symptoms, diagnose conditions using the Sunrise at-home sleep test device and create personalized treatment plans.
More information on Sunrise’s diagnostic tools and digital clinic partnerships is available here.
